Clinical Trials · NCT05218915

Basal Plus GLP1-ra on Glycemic Variability in CKD

Name: Basal Plus GLP1-ra on Glycemic Variability in CKD
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Dulaglutide

Phase: Phase 4
Recruitment status: Completed
Sponsor: Elaine Chow
Enrollment: 95
Start date: Jan 2022
Locations: 1 site, Hong Kong
Primary endpoint: Glycemic variability

View Dulaglutide compound reference